Global Pharmaceutical Continuous Manufacturing Technology Market: Snapshot
In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.
Other advantages of pharmaceutical continuous manufacturing technology is the superior development speeds, higher process safety when employing hazardous chemistries, and the opportunity to perform reactions that cannot be run under batch processing.
A study by Transparency Market Research forecasts the global pharmaceutical continuous manufacturing technology market to expand at a healthy CAGR of 8.8% from 2017 to 2025. Expanding at this pace, the market which was worth US$1.74 bn in 2016 is expected to attain a value of US$3.693 bn in 2025.
Contract Manufacturing Organizations in Asia Pacific to Drive Market
Some of the key application segments of the global pharmaceutical continuous manufacturing technology market are biologics, dry powders, active pharmaceutical ingredients, etc. Of them, the segment of biologics accounts for a dominant position in the market. It held a share of about 35.3% in the global market in 2016. It was trailed by active pharmaceutical ingredient.
Application-wise, the global pharmaceutical continuous manufacturing technology market can be divided into contract manufacturing organizations, pharmaceutical companies, etc. Currently, pharmaceutical companies lead the market with maximum demand and are trailed by contract manufacturing organizations. In the near future, the contract manufacturing organizations in Asia Pacific region are predicted to fuel market growth majorly. Along with increasing awareness about the technology, various initiatives by FDA are also egging manufacturers to shift to continuous manufacturing over batch manufacturing process.
Demand for Better Technology Propels Europe Market to Fore
From a geographical standpoint, currently Europe dominates the global pharmaceutical continuous manufacturing technology market. Strong demand for advanced technology from pharmaceutical companies and presence of many contract manufacturing entities has majorly fuelled the market in the region. The growth in Europe is primarily powered by the U.K. and Germany. The region’s leading share in 2016 came to around 35%. The market in the region is also expected to outshine others in terms of growth by registering a CAGR of 9.6% in the forecast period. Expanding at this pace, it is predicted to clock a revenue of US$1.38 bn by 2025. This is mainly on account of the early availability of advanced technologies and greater number of technology providers across the region.
Asia Pacific trails Europe vis-à-vis market share. In 2016, the region held a share of about 34% in the global pharmaceutical continuous manufacturing market. The growth in Asia Pacific has been mainly driven by China and India, which are home to numerous contract manufacturing organizations. China is considered a highly promising market because of increasing acceptability of technologically advanced continuous manufacturing and growing awareness about the advantages of the technology.
North America comes in the third position in terms of market size. Initiatives by FDA to switch from current batch process to continuous manufacturing technology drives interest among the pharmaceutical companies.
Some of the prominent participants in the global pharmaceutical continuous manufacturing technology market are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, and Chemtrix.
Global Pharmaceutical Continuous Manufacturing Technology Market: Overview
This report on pharmaceutical continuous manufacturing technology market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global pharmaceutical continuous manufacturing technology market with respect to the leading market segments based on major products segment, end users, and geographies.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pharmaceutical continuous manufacturing technology market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pharmaceutical continuous manufacturing technology market.
Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Pharmaceutical Continuous Manufacturing Technology Market: Segmentation
Based on the application type, the pharmaceutical continuous manufacturing technology market has been segmented into: active pharmaceutical ingredient, biologics, dry powders & others. In term of end-users products divided into pharmaceutical companies, contract manufacturing organizations and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing awareness worldwide, technological advancement, and growing number of user in various geographies.
Geographically, pharmaceutical continuous manufacturing technology market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions.
Global Pharmaceutical Continuous Manufacturing Technology Market: Competitive Analysis
A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global pharmaceutical continuous manufacturing technology market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global pharmaceutical continuous manufacturing technology market. The report also profiles key players operating in the pharmaceutical continuous manufacturing technology market which are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, Chemtrix, Ehrfeld etc.
The global pharmaceutical continuous manufacturing technology market is segmented as follows:
Global Pharmaceutical continuous manufacturing technology Market, by Application Type
- Active Pharmaceutical ingredient
- Dry Powders
Global Pharmaceutical continuous manufacturing technology Market, by End-users
- Pharmaceutical Companies
- Contract Manufacturing Organizations
Global Pharmaceutical continuous manufacturing technology Market, by Geography
- North America
- Rest of the Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia
- Latin America (LATAM)
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa